
Bacterial outer membrane vesicles as cationic dye carriers for ...
2023年4月17日 · We demonstrate that cationic dyes (IR780, Cy7, and Cy7.5) form stable complexes with negatively charged bacterial-OMVs, improving the dyes’ in vivo circulation and …
细菌外膜囊泡(OMV)体内生物安全性实验(五) - 知乎
2023年8月14日 · 监测单次静脉注射(×1)或多次静脉注射(×3, ×5)给药的Cyanine7 (Cy7)标记的OMV在肿瘤中的积累,其中只在最后一次注射中使用 Cy7标记 的OMV。 虽然在×1组中标记 …
Hybrid Outer Membrane Vesicles with Genetically Engineering for ...
2025年2月14日 · In this study, bone marrow-derived mesenchymal stem cells (BMSCs) are genetically engineered to overexpress CXCR4 and isolated cell membranes (mBMSC CXCR4) …
Engineered bacterial outer membrane vesicles: a versatile bacteria ...
Nevertheless, emerging evidence reflected shortcomings of native OMV in tumor therapy recently. Kim et al. labeled OMVs with Cyanine7 (Cy7) and detected different levels of OMVs …
Bacterial outer membrane vesicles suppress tumor by interferon …
2017年9月20日 · Cy7-labeled OMVs (10 μg in total protein) were injected intravenously to normal mice and mice bearing tumor with a diameter of 15 mm (male, 8 weeks old).
Antigen-bearing outer membrane vesicles as tumour vaccines
2022年5月2日 · Here we show that outer membrane vesicles (OMVs) fused to a tumour antigen and produced in the intestine by ingested genetically engineered bacteria function as effective …
We demonstrate that cationic dyes (IR780, Cy7, and Cy7.5) form stable com-plexes with negatively charged bacterial-OMVs, improving the dyes’ in vivo circulation and optoacoustic …
细菌外膜囊泡(OMV)体内生物安全性实验最全总结 - 知乎
2023年8月15日 · 开发了一种装载PD-1质粒的LyP1多肽修饰的外膜囊泡 (LOMV),以实现PD-L1在肿瘤细胞中的自阻断。 纳米载体通过OMV靶向能力在肿瘤组织中积累,并通过lyP1介导的靶 …
Targeting of E. coli ΔmsbB OMVs to tumor tissues after systemic ...
Targeting of E. coli ΔmsbB OMVs to tumor tissues after systemic administration. a Cy7 control and Cy7-labeled E. coli ΔmsbB OMVs (ΔmsbB Cy7 OMVs) were systematically injected to …
Bioengineered bacteria-derived outer membrane vesicles as a …
2021年4月6日 · Outer membrane vesicles (OMVs) can strongly activate the innate immune system and are qualified as immunoadjuvants. Here, we describe a versatile OMV-based …